Assuring the quality of examinations using faecal immunochemical tests for haemoglobin (FIT)

doi:https://doi.org/10.17116/labs2021100117

Journal: Laboratory Service. 2021;10(1): 7‑9

DOI: 10.17116/labs2021100117

Read: 1032 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Assuring the quality of examinations using faecal immunochemical tests for haemoglobin (FIT). Laboratory Service. 2021;10(1):7‑9. (In Russ.)
https://doi.org/10.17116/labs2021100117

Подписка 2025 Лабораторная служба (Laboratory Service)

Использование инфографики авторами научных работ

Close metadata

Abstract:

Fecal immunochemical tests (FIT) for hemoglobin are now considered the best noninvasive test for screening for colorectal cancer and are used as standard or supplemental screening worldwide. FITs are also part of patient follow-up programs after polyp removal. In addition, judging by the growing body of data in recent years, FIT combined with clinical evaluation is a useful tool for deciding which primary patients with symptoms of lower bowel lesions see benefit from further investigations, such as bowel imaging.

Close metadata

References:

Robertson DJ, Selby K. Fecal immunochemical test: the world’s colorectal cancer screening test. Gastrointest Endosc Clin N Am. 2020;30:511-526.
Young GP, Woodman RJ, Symonds E. Detection of advanced colorectal neoplasia and relative colonoscopy workloads using quantitative faecal immunochemical tests: an observational study exploring the effects of simultaneous adjustment of both sample number and test positivity threshold. BMJ Open Gastroenterol. 2020;7:e000517.
Godber IM, Benton SC, Fraser CG. Setting up a service for a faecal immunochemical test for haemoglobin (FIT): a review of considerations, challenges and constraints. J Clin Pathol. 2018;71:1041-1045.
Allison JE, Fraser CG, Halloran SP, Young GP. Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT). Gut Liver. 2014;8:117-130.
D’Souza N, Abulafi M. Navigating the storm of COVID-19 for patients with suspected bowel cancer. Br J Surg. 2020;107:e204.
Clark GRC, Strachan JA, McPherson A, Digby J, Mowat C, Steele RJC et al. Faecal haemoglobin distributions by sex, age, deprivation and geographical region: consequences for colorectal cancer screening strategies. Clin Chem Lab Med. 2020;58:2073-2080.
International Organization for Standardization. ISO. Medical laboratories — Requirements for quality and competence (ISO 15189); 2012.
Piggott C, Shugaa Z, Benton SC. Independent internal quality control (IQC) for faecal immunochemical tests (FIT) for haemoglobin: use of FIT manufacturers’ IQC for other FIT systems. Clin Chem Lab Med. 2021;59:e41-43.
Piggott C, Carroll MRR, John C, O’Driscoll S, Benton SC. Analytical evaluation of four faecal immunochemistry tests for haemoglobin. Clin Chem Lab Med. 2021;59:173-178.
O’Driscoll S, Piggott C, Bruce H, Benton SC. An evaluation of ten external quality assurance scheme (EQAS) materials for the faecal immunochemical test (FIT) for haemoglobin. Clin Chem Lab Med. 2021;59:307-313.